Primary care practitioners should be aware of 3 new FDA approvals that may be useful when treating patients with cervical cancer, multiple sclerosis, and insomnia.
The FDA approved a once-daily, long-term olodaterol inhalation spray to treat patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema with airflow obstruction.